JonathanMMeyerMD
Psychiatry • San Diego, CAVol Clinical Professor of Psychiatry at University of California, San Diego
Dr. Meyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12974 Carmel Creek Rd
Ste 180
San Diego, CA 92130Phone+1 858-964-0777
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Consultation-Liaison Psychiatry, 1996 - 1997- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Psychiatry, 1993 - 1995
Cedars-Sinai Medical CenterResidency, Psychiatry, 1992 - 1993- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1988 - 1990
Harvard Medical SchoolClass of 1988
Certifications & Licensure
CA State Medical License 1989 - 2025
OR State Medical License 1998 - 2004- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Distinguished Life Fellow American Psychiatric Association, 2018
Clinical Trials
- Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study Start of enrollment: 2003 Jul 01
- Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes Start of enrollment: 2006 Jun 01
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 188 citationsA retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: Metabolic outcomes after 1 yearJonathan M. Meyer
The Journal of Clinical Psychiatry. 2002-05-12 - 371 citationsA comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controlsDonald C. Goff, Lisa M. Sullivan, Joseph P. McEvoy, Jonathan M. Meyer, Henry A. Nasrallah
Schizophrenia Research. 2005-12-01 - 805 citationsPrevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schi...Joseph P. McEvoy, Jonathan M. Meyer, Donald C. Goff, Henry A. Nasrallah, Sonia M. Davis
Schizophrenia Research. 2005-12-01
Books/Book Chapters
Press Mentions
Dr. Jonathan Meyer on Treating Schizophrenia: Lessons Learned and Future DirectionsSeptember 9th, 2020
How to Manage Ultra-Resistant SchizophreniaFebruary 4th, 2020
Grant Support
- The Metabolic Syndrome In Patients With SchizophreniaNational Center For Research Resources2007–2010
- Acute Impact Of Antipsychotics On Insulin Sensitivity: A Novel Human ModelNational Institute Of Mental Health2008–2009
- The Metabolic Syndrome In Patients With Schizophrenia - Extension StudyNational Center For Research Resources2008–2009
- The Metabolic Syndrome In Patients With SchizophreniaNational Institute Of Mental Health2005–2009
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
